GAP-Net

GAP-Net (Global Alzheimer's Platform Network) is a standing network of high-performing clinical trial sites across North America dedicated to accelerating the delivery of innovative therapies for Alzheimer's disease. Established by the Global Alzheimer's Platform Foundation, the network aims to reduce the time, cost, and complexity of Alzheimer's clinical trials through standardized processes and shared resources. GAP-Net provides sponsors with access to a curated group of academic and private research sites that specialize in neurodegenerative disorders. The organization focuses on improving recruitment efficiency, enhancing data quality, and ensuring diversity in clinical trial participation. By fostering collaboration between industry, academia, and trial sites, GAP-Net serves as a critical infrastructure for the Alzheimer's research community.